Abstract:Background Matrix metalloproteinases ( MMPs) are the major regulators of collagen degradation involved in the pathogenesis of several diseases of the heart. The purpose of this study was to investigate the dynamic changes in myocardial MMP activity in mice with viral myocarditis (VM), the relationship between MMP activity and both cardiac function and the quantity of myocardial collagen, and the role MMPs playing in the pathological lesions of VM.Methods Sixty-five six-week-old male DBA/2 mice were divided into two groups. Mice in the infected group (n = 50) were inoculated intraperitoneally with 0.14 ml of Coxsackievirus B-3 (CVB3, Nancy strain). Control mice (n = 15) were inoculated intraperitoneally with 0.14 ml of Eagle's medium. Eight infected mice and three control mice were sacrificed on each of days 3, 7, 10, 21 and 30 after inoculation. MMP activity was measured on an SDS-PAGE substrate gel embedded with type I gelatin (zymography). Echocardiographic studies were performed under anesthesia with 3% chloralhydrate administered intraperitoneally (0.01 ml/g - 0.015 ml/g). Cardiac systolic function indices, such as peak velocity of the aorta (V-p), flow velocity integral of the aorta (V-i), ejection fraction (EF), and fractional shortening (FS) were determined by echocardiography. Histological cross sections of the hearts were stained with hematoxylin-eosin and myocardial histopathological scores were determined under an optical microscope. The amount of myocardial collagen was measured by means of hydroxyproline quantification.Results In virus-infected mice, both MMP-2 and MMP-9 activities were significantly higher than in control mice, reaching a peak on day 10 ( P < 0.01). On day 10, cardiac systolic function indices (EF, FS, V-p, and V-i) were all significantly lower compared both to other stages following viral inoculation and to the control group (P < 0.05). In the acute stage, the amount of myocardial collagen in mice with VM was not significantly different from normal control mice (P > 0.05). However, the amount of myocardial collagen in infected I mice at the recovery stage (on days 21 and 30) was significantly greater than those of the control mice. MMP-2 and MMP-9 activities positively correlated with myocardial histopathological scores (r = 0.801, 0.821, P < 0.01) and negatively correlated with V-p (r = -0.649, -0.683, P < 0.01) and V-i (r = -0.711, -0.755, P < 0.01). However, V-p negatively correlated with myocardial histopathological scores (r = -0.756, P < 0.01).Conclusions In mice with VM, the activities of myocardial MMP-2 and MMP-9 increase significantly during the acute stage, and the total quantity of myocardial collagen increases by the time of recovery. These changes are associated with myocardial interstition remodeling and cardiac dysfunction. MMP activity is an important reference marker for myocardial pathological lesions and can be used to evaluate the severity of myocardial interstitial damage and cardiac dysfunction.

Relationship between the Activity of Matrix Metalloproteinase-2 and -9 in Myocardial Homogenate with Changes of the Cells Composition in the Coronary Arteries Wall in the Experiment

Relationship Between Matrix Metalloproteinase-9 and Tissue Metalloproteinase Inhibitor-1 and Carotid Atheromatous Plaque Stability

Value of Matrix Metalloproteinase - 9 and Ischemia - Modified Albumin for Diagnosis of Coronary Heart Disease

The clinic relevance between acute coronary syndrome and the level of serum matrix metalloproteinase-9

Temporal and Quantitative Analysis of Expression of Metalloproteinases (mmps) and Their Endogenous Inhibitors in Atherosclerotic Lesions.

The Expression of Matrix Metalloproteinases-9, Transforming Growth Factor-Beta1 and Transforming Growth Factor-Beta Receptor I in Human Atherosclerotic Plaque and Their Relationship with Plaque Stability.

The relationship of the gene polymorphisms of matrix metalloproteinase-1, -2, -3 and -9 to the progression of coronary atherosclerotic plaque

Abstract Tu010: Matrix Metallopeptidase 9 Contributes to the Beginning of Plaque and is a Potential Biomarker for the Early Identification of Atherosclerosis in Asymptomatic Patients with Diabetes

Comparative study of tissue expressions of matrix metalloproteinase-9 in human abdominal aortic aneurysms and arterial occlusive diseases

Matrix metallopeptidase 9 contributes to the beginning of plaque and is a potential biomarker for the early identification of atherosclerosis in asymptomatic patients with diabetes

Correlation Between Coronary Atherosclerotic Plaques and MMP2,MMP9 Levels

[Plasma Matrix Metalloproteinases-2 and -9 Levels Are Elevated in Patients with Acute Coronary Syndrome and Coronary Chronic Total Occlusion].

Matrix Metalloproteinase 9 as a Predictor of Coronary Atherosclerotic Plaque Instability in Stable Coronary Heart Disease Patients with Elevated Lipoprotein(a) Levels

Gene expression levels of matrix metalloproteinases in human atherosclerotic plaques and evaluation of radiolabeled inhibitors as imaging agents for plaque vulnerability

Significance of the Detection of Serum Levels of Matrix Metalloproteinases -1,-2,-3 and -9 in Thoracic Aortic Diseases and Acute Myocardial Ischemia

Assessment of the Level of Matrix Metalloproteinases, VEGF and MicroRNA-34a in Patients With Non-obstructive and Obstructive Lesions of the Coronary Arteries

Plasma Levels of Matrix Metalloproteinase-2 and Tissue Inhibitor of Matrix Metalloproteinase-2 and Its Relationship with Acute Coronary Syndrome

Increased Expression of 72-Kd Type IV Collagenase (MMP-2) in Human Aortic Atherosclerotic Lesions.

Dynamic Changes in Myocardial Matrix Metalloproteinase Activity in Mice with Viral Myocarditis.

Clinical Value of Combined Assay of Serumal Matrix Metalloproteinases-9 and C-reactive Protein in Patients with Coronary Artery Disease

[Myocardial Matrix Metalloproteinases Activities in Mice with Viral Myocarditis and Their Relationship with Cardiac Function and Myocardial Collagen Amount].